Immunostimulatory oligodeoxynucleotide from Bifidobacterium longum suppresses Th2 immune responses in a murine model

Clinical and Experimental Immunology

Volumn 145, Issue 1, 2006, Pages 130-138

  Takahashi, N ^a   Kitazawa, H ^b   Iwabuchi, N ^a   Xiao, J Z ^a   Miyaji, K ^a   Iwatsuki, K ^a   Saito, T ^b  

^a MORINAGA MILK INDUSTRY CO LTD   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

Allergy; Bifidobacterium longum BB536; Ige; ISS ODN; Probiotics

Indexed keywords

ANTIGEN; GAMMA INTERFERON; GENOMIC DNA; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; OLIGODEOXYNUCLEOTIDE BL07S; OLIGODEOXYNUCLEOTIDE DERIVATIVE; OVALBUMIN; PROBIOTIC AGENT; UNCLASSIFIED DRUG;

ALLERGIC REACTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIFIDOBACTERIUM LONGUM; CONTROLLED STUDY; IMMUNE RESPONSE; IMMUNOSTIMULATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; TH2 CELL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BIFIDOBACTERIUM; BIOLOGICAL MARKERS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOSUPPRESSION; INTERLEUKIN-4; INTERLEUKIN-5; MALE; MICE; MICE, INBRED BALB C; OLIGODEOXYRIBONUCLEOTIDES; OVALBUMIN; PROBIOTICS; RESPIRATORY HYPERSENSITIVITY; SPLEEN; TH2 CELLS;

EID: 33745180845     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2006.03111.x     Document Type: Article

References (36)

1. Lee BW Geha RS Leung DY. IgE response and its regulation in allergic diseases. Pediatr Clin North Am 1988 35 : 953 67.
2. Romagnani S. Regulation of the development of type 2 T-helper cells in allergy. Curr Opin Immunol 1994 6 : 838 46.
3. Kapsenberg ML Jansen HM Bos JD Wierenga EA. Role of type 1 and type 2 T helper cells in allergic diseases. Curr Opin Immunol 1992 4 : 788 93.
4. Kidd P. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern Med Rev 2003 8 : 223 46.
5. Bochner BS Lichtenstein LM. Anaphylaxis. N Engl J Med 1991 324 : 1785 90.
6. Fuller R. Probiotics in man and animals. J Appl Bacteriol 1989 66 : 365 78.
7. Shida K Makino K Morishita A et al. Lactobacillus casei inhibits antigen-induced IgE secretion through regulation of cytokine production in murine splenocyte cultures. Int Arch Allergy Immunol 1998 115 : 278 87.
8. Matsuzaki T Yamazaki R Hashimoto S Yokokura T. The effect of oral feeding of Lactobacillus casei strain Shirota on immunoglobulin E production in mice. J Dairy Sci 1998 81 : 48 53.
9. Ishida Y Bandou I Kanzato H Yamamoto N. Decrease in ovalbumin specific IgE of mice serum after oral uptake of lactic acid bacteria. Biosci Biotechnol Biochem 2003 67 : 951 7.
10. Kimoto H Mizumachi K Okamoto T Kurisaki J. New Lactococcus strain with immunomodulatory activity. enhancement of Th1-type immune response. Microbiol Immunol 2004 48 : 75 82.
11. Ohno H Tsunemine S Isa Y Shimakawa M Yamamura H. Oral administration of Bifidobacterium bifidum G9-1 suppresses total and antigen specific immunoglobulin E production in mice. Biol Pharm Bull 2005 28 : 1462 6.
12. Ishida Y Nakamura F Kanzato H et al. Effect of milk fermented with Lactobacillus acidophilus strain L-92 on symptoms of Japanese cedar pollen allergy: a randomized placebo-controlled trial. Biosci Biotechnol Biochem 2005 69 : 1652 60.
13. Xiao JZ Kondo S Yanagisawa N et al. Effect of probiotic Bifidobacterium longum BB536 in relieving clinical symptoms and modulating plasma cytokine levels of Japanese cedar pollinosis during the pollen season, a randomized, double-blind, placebo-controlled trial. J Invest Allergol Clin Immunol 2006 16 : 86 93.
14. Matsuguchi T Takagi A Matsuzaki T et al. Lipoteichoic acids from Lactobacillus strains elicit strong tumor necrosis factor alpha-inducing activities in macrophages through Toll-like receptor 2. Clin Diagn Lab Immunol 2003 10 : 259 66.
15. Pena JA Versalovic J. Lactobacillus rhamnosus GG decreases TNF-alpha production in lipopolysaccharide-activated murine macrophages by a contact-independent mechanism. Cell Microbiol 2003 5 : 277 85.
16. Krieg AM Yi AK Matson S et al. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 1995 374 : 546 9.
17. Kitazawa H Ueha S Itoh S et al. AT oligonucleotides inducing B lymphocyte activation exist in probiotic Lactobacillus gasseri. Int J Food Microbiol 2001 65 : 149 62.
18. Kitazawa H Watanabe H Shimosato T Kawai Y Itoh T Saito T. Immunostimulatory oligonucleotide, CpG-like motif exists in Lactobacillus delbrueckii ssp. bulgaricus NIAI B6. Int J Food Microbiol 2003 85 : 11 21.
19. Iliev ID Kitazawa H Shimosato T et al. Strong immunostimulation in murine immune cells by Lactobacillus rhamnosus GG DNA containing novel oligodeoxynucleotide pattern. Cell Microbiol 2005 7 : 403 14.
20. Shimosato T Kimura T Tohno M et al. Strong immunostimulatory activity of AT-oligodeoxynucleotide requires a six-base loop with a self-stabilized 5′-C...G-3′ stem structure. Cell Microbiol 2006 8 : 485 95.
21. Hemmi H Takeuchi O Kawai T et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000 408 : 740 5.
22. Klinman DM Yi AK Beaucage SL Conover J Krieg AM. CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma. Proc Natl Acad Sci 1996 93 : 2879 83.
23. Klinman DM. Immunotherapeutic uses of CpG oligodeoxynucleotides. Nat Rev Immunol 2004 4 : 249 58.
24. Creticos PS Chen YH Schroeder JT. New approaches in immunotherapy: allergen vaccination with immunostimulatory DNA. Immunol Allergy Clin North Am 2004 24 : 569 81.
25. Takahashi N Kitazawa H Shimosato T et al. An immunostimulatory DNA sequence from a probiotic strain of Bifidobacterium longum inhibits IgE production in vitro. FEMS Immunol Med Microbiol 2006 46 : 461 9.
26. Nakao A Kasai M Kumano K Nakajima H Kurasawa K Iwamoto I. High-dose oral tolerance prevents antigen-induced eosinophil recruitment into the mouse airways. Int Immunol 1998 10 : 387 94.
27. Sato Y Akiyama H Suganuma H et al. The feeding of beta-carotene down-regulates serum IgE levels and inhibits the type I allergic response in mice. Biol Pharm Bull 2004 27 : 978 84.
28. Sur S Wild JS Choudhury BK Sur N Alam R Klinman DM. Long term prevention of allergic lung inflammation in a mouse model of asthma by CpG oligodeoxynucleotides. J Immunol 1999 162 : 6284 93.
29. Bohle B. CpG motifs as possible adjuvants for the treatment of allergic diseases. Int Arch Allergy Immunol 2002 129 : 198 203.
30. Yi AK Chang M Peckham DW Krieg AM Ashman RF. CpG oligodeoxyribonucleotides rescue mature spleen B cells from spontaneous apoptosis and promote cell cycle entry. J Immunol 1998 160 : 5898 906.
31. Hartmann G Weeratna RD Ballas ZK et al. Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune response in vitro and in vivo. J Immunol 2000 164 : 1619 24.
32. Kline JN Krieg AM Waldschmidt TJ Ballas ZK Jain V Businga TR. CpG oligodeoxynucleotides do not require Th1 cytokines to prevent eosinophilic airway inflammation in a murine model of asthma. J Allergy Clin Immunol 1999 104 : 1258 64.
33. Wing K Suri-Payer E Rudin A. CD4+CD25+-regulatory T cells from mouse to man. Scand J Immunol 2005 62 : 1 15.
34. Moseman EA Liang X Dawson AJ et al. Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells. J Immunol 2004 173 : 4433 42.
35. Liu N Ohnishi N Ni L Akira S Bacon KB. CpG directly induces T-bet expression and inhibits IgG1 and IgE switching in B cells. Nat Immunol 2003 4 : 687 93.
36. Peng SL Li J Lin L Gerth A. The role of T-bet in B cells. Nat Immunol 2003 4 : 1041.